5-Thiazolecarboxylic Acid, Ethyl Ester

In kilogram-scale campaigns producing the oral Factor Xa inhibitor edoxaban, ethyl 5-thiazolecarboxylate is deployed not as a peripheral fragment but as the direct precursor to the P4 pharmacophore unit. Process development records from pilot-plant batches indicate that the ester is converted to 5-thiazolecarbonyl chloride via treatment with thionyl chloride in toluene at 65–70 °C under a nitrogen sweep to evacuate HCl and SO₂. The resulting acid chloride exhibits a half-life of less than 45 minutes in ambient moisture—an operational boundary mandating a strictly anhydrous work environment with relative humidity held below 15% RH, monitored by in-line panametrics probes. Coupling with (1S,3R,4S)-4-amino-3-[(tert-butoxycarbonyl)amino]cyclohexane-1-carboxylic acid methyl ester proceeds in dichloromethane at −5 °C to 0 °C, employing 1.05–1.10 molar equivalents of triethylamine. Failure to maintain the substoichiometric excess of base above 1.08 eq has been correlated with dimerization of the acid chloride, generating a des-thiazole dimer impurity at 0.3–0.7% HPLC area that co-elutes with the desired amide on C18 stationary phases under isocratic acetonitrile/water conditions. The crude amide is crystallized from ethyl acetate/n-heptane (1:3 v/v) to yield > 99.5% chemical purity with enantiomeric excess exceeding 99.9% as measured by chiral HPLC using a Chiralpak AD-H column. Subsequent Boc deprotection with HCl in isopropanol liberates the primary amine that is condensed with the oxazolidinone-activated carboxylate to complete the edoxaban backbone. The entire sequence conforms to ICH Q3A guidelines for residual solvents; residual toluene in the final isolated intermediate is controlled below 890 ppm as verified by headspace GC per USP <467>. This exacting moisture-sensitive amidation chemistry illustrates why ethyl 5-thiazolecarboxylate, despite its apparent simplicity, demands rigorous engineering controls when scaled to 50 kg input lots.

What Makes the Thiazole-5-carboxylate Scaffold a Privileged Antifungal Pharmacophore?

A structurally distinct application involves the construction of thiazole-containing antifungal agents related to the clinical candidate abafungin. In this synthetic route, ethyl 5-thiazolecarboxylate serves as the electrophilic partner in a lithium diisopropylamide-mediated condensation with 2-aminothiophenol at −78 °C in tetrahydrofuran. The reaction proceeds through a tetrahedral intermediate that cyclizes upon warming to 20 °C over 4 hours, extruding ethanol and furnishing a thiazolo-benzothiazole hybrid. Pilot-scale kinetic profiling using ReactIR has determined that the elimination of ethanol becomes rate-limiting below −50 °C, causing accumulation of the open-chain adduct that degrades via β-elimination to a vinyl thiazole side product, reducing the effective yield by 12–18%. Accordingly, the cyclization is triggered by controlled warming at a rate of 0.5 °C/min with continuous distillation of the evolving ethanol/tetrahydrofuran azeotrope. The final heterocyclic product is isolated as the hydrobromide salt by addition of anhydrous HBr in acetic acid, filtered under nitrogen, and dried at 40 °C and 5 mbar for 18 hours. The product must conform to European Pharmacopoeia monograph 10.0, 01/2023:2628 for related substances, with any single unspecified impurity limited to ≤0.10%. Observance of this cooling ramp specification and azetropic removal is absent in earlier patent literature but proves critical in campaigns exceeding 20 kg, as documented in process validation master plans filed under EU GMP Part I Chapter 4.

In the domain of coordination chemistry, the utilization of 5-thiazolecarboxylic acid—obtained quantitatively by saponification of the ethyl ester with 1.0 M aqueous NaOH at 50 °C for 2 hours—as a bifunctional linker in metal-organic frameworks (MOFs) has been explored for the construction of heterobimetallic nodes. The free acid precipitates at pH 2.0–2.5 upon neutralization with dilute HCl, and its isoelectric point lies at approximately pH 3.1. Single-crystal X-ray diffraction data confirm that the thiazole nitrogen and the carboxylate oxygen atoms chelate Cu(II) centers in a distorted square-pyramidal geometry, forming one-dimensional chains that are interconnected via 4,4′-bipyridine pillars. Solvothermal synthesis in a Teflon-lined autoclave using a mixture of DMF/ethanol/water (2:1:1 v/v/v) at 85 °C for 48 hours yields dark blue crystals of composition [Cu₂(5-tza)₂(bpy)₂]·2DMF. BET surface area measured by nitrogen adsorption at 77 K after activation at 120 °C under vacuum gives a Langmuir surface area of 1,150 m²/g and a pore volume of 0.62 cm³/g at P/P₀ = 0.95. This MOF exhibits selective adsorption of CO₂ over N₂ at 298 K with a selectivity factor of 28 calculated from single-component isotherms by ideal adsorbed solution theory, which is superior to several zinc-based IRMOFs. Practical utility in gas separation membranes, however, is limited by the framework's gradual decomposition at relative humidity above 60%, as confirmed by PXRD monitoring over 7 days; the thiazole nitrogen undergoes protonation by residual water, leading to amorphization. Workarounds involving post-synthetic acetylation of the uncoordinated nitrogen site are under investigation but currently exhibit only 40% conversion efficiency.

Conformationally Constrained Peptidomimetics Incorporating Ethyl 5-Thiazolecarboxylate

In the design of β-secretase (BACE1) inhibitors, the thiazole ring functions as a non-classical amide bioisostere that restricts the ψ and φ torsional angles of the adjacent amino acid residues. Ethyl 5-thiazolecarboxylate is elaborated into a trans-5-substituted L-proline surrogate via a Horndes-homologation sequence. First, the ester is reduced with lithium aluminum hydride in diethyl ether at 0 °C to 5-hydroxymethylthiazole, which is then oxidized with Dess-Martin periodinane to the aldehyde. The crude aldehyde is directly subjected to a Wittig reaction with (carbethoxymethylene)triphenylphosphorane in dichloromethane at reflux for 12 hours, providing the α,β-unsaturated ester with an E:Z ratio of 94:6. Conjugate addition of the lithium enolate of glycine tert-butyl ester at −78 °C and subsequent hydrogenolysis of the benzyl carbamate protecting group install the requisite (S)-configuration at the α-carbon with diastereomeric excess > 96%. When this building block is incorporated into the P1–P2′ sequence of a peptidomimetic inhibitor, it introduces a rigid kink that pre-positions the P1 phenylalanine side chain into the S1 pocket of the enzyme. Isothermal titration calorimetry measurements reveal a binding enthalpy of −8.7 kcal/mol, compared to −5.4 kcal/mol for the flexible ethylenediamino analog, attributable to entropic stabilization from reduced conformational freedom. The isolated inhibitor is tested for cellular activity in SH-SY5Y cells expressing human BACE1, showing an IC₅₀ of 38 nM in the FRET-based assay. It should be noted that the methylene alcohol intermediate generated during the reduction step is a potent skin sensitizer, classified as H317 under CLP Regulation (EC) No 1272/2008; engineering controls with closed-loop containment and LEV with face velocity of 0.5 m/s are mandatory during its handling.

Within agrochemical process chemistry, the integration of ethyl 5-thiazolecarboxylate into a pipeline for acaricide intermediates was driven by structure-activity relationship data gathered on the flometoquin scaffold. The ethyl ester is transesterified with 2,2,2-trifluoroethanol in the presence of titanium(IV) isopropoxide (5 mol%) in toluene under Dean-Stark reflux for 8 hours, affording 2,2,2-trifluoroethyl 5-thiazolecarboxylate at 92% isolated yield. The trifluoroethyl ester displays heightened electrophilicity, facilitating direct amidation with 4-(trifluoromethoxy)aniline at 23 °C over 2 hours without catalyst. The resulting thiazole-5-carboxamide is then subjected to directed ortho-lithiation using n-butyllithium in THF at −40 °C, followed by quenching with N-fluorobenzenesulfonimide to install a fluorine atom at the 4-position of the thiazole ring. This fluorination step represents the critical process bottleneck: the lithiation exotherm must be controlled below −35 °C to avoid deprotonation of the amide NH, which results in a competing degradation pathway that precipitates the lithium amide as an insoluble gum, obstructing the impeller shaft of the cryogenic reactor. A cascaded temperature control strategy with a jacket setpoint of −50 °C and a controlled addition rate of 0.4 eq/h n-BuLi mitigates this risk, maintaining reaction mixture homogeneity throughout the lithiation period of 3.5 hours. The validated process produces 95 kg of the fluorinated intermediate per batch with an impurity profile compliant with FAO specifications for technical active ingredient manufacturing; 4-methylthiazole-related substances are kept below 0.15% by integrating an acidic wash with 10% aqueous citric acid.

When the Ester Serves as a Latent Aldehyde Equivalent in Heterocyclic Telescoped Sequences

A less intuitive role emerges in palladium-catalyzed decarboxylative cross-coupling where ethyl 5-thiazolecarboxylate is not the end product but a masked aldehyde precursor. Saponification to the acid and subsequent conversion to an N-acyloxyphthalimide redox-active ester (RAE) sets the stage for photoredox-mediated alkylation under blue LED irradiation (456 nm) using an iridium(III) photocatalyst [Ir(dF(CF₃)ppy)₂(dtbbpy)]PF₆ at 0.5 mol% loading. The decarboxylative coupling with a diverse set of secondary alkyl bromides proceeds at 25 °C in DMF within 16 hours, producing 5-alkylthiazoles that retain the ethyl carboxylate functionality or, depending on the bromide counterpart, undergo in situ DIBAL-H reduction of the ester to the aldehyde. This telescoped sequence circumvents the need for cryogenic conditions typically required for direct formylation of 5-lithiothiazole, which suffers from low yields (≤40%) due to competitive ring-opening. Quenching the DIBAL-H reduction with saturated aqueous Rochelle salt at 0 °C liberates the aldehyde that is immediately used in reductive amination with morpholine using sodium triacetoxyborohydride (1.5 eq) in 1,2-dichloroethane. The entire flow sequence—from redox-active ester formation through aldehyde generation and reductive amination—has been demonstrated in a continuous-flow PFA tubular reactor with a residence time of 22 minutes per stage, achieving a throughput of 120 g/h. Deployment of this methodology in target-directed synthesis of Janus kinase (JAK) inhibitor candidates has been reported, with isolated yields of the penultimate thiazole-carbaldehyde intermediate reaching 67% over three chemical steps without isolation.